There must be a way out of here: identifying a safe and efficient combination of promoter, transgene, and vector backbone for gene therapy of neurological disease.
Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA. Electronic address: pedrol@umich.edu.
P R
PR
Lowenstein
Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Viveka Nand
VN
Yadav
Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Peter
P
Chockley
Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Maria
M
Castro
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism*; D002490:Central Nervous System / Q000276:immunology* / Q000378:metabolism*; D000229:Dependovirus; D005822:Genetic Vectors; D006801:Humans; D007249:Inflammation / Q000235:genetics* / Q000276:immunology*